Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

Synthesis, biological evaluation and computational studies of pyrazole derivatives as Mycobacterium tuberculosis CYP121A1 inhibitors.
Alshabani, LA; Kumar, A; WILLCOCKS, SJ; Srithiran, G; Bhakta, S; Estrada, DF; Simons, C;
2022
RSC Medicinal Chemistry, (2022).13 11 10.1039/d2md00155a.
Forgiveness Is the Attribute of the Strong: Nonadherence and Regimen Shortening in Drug-sensitive Tuberculosis.
STAGG, HR; THOMPSON, JA; Lipman, MC I; Sloan, DJ; Flook, M; FIELDING, KL;
2022
American journal of respiratory and critical care medicine, (2022).207 2 10.1164/rccm.202201-0144OC.
A data compendium associating the genomes of 12,289 Mycobacterium tuberculosis isolates with quantitative resistance phenotypes to 13 antibiotics.
The CRyPTIC Consortium,;
2022
PLoS biology, (2022).20 8 10.1371/journal.pbio.3001721.
Genome-wide association studies of global Mycobacterium tuberculosis resistance to 13 antimicrobials in 10,228 genomes identify new resistance mechanisms.
The CRyPTIC Consortium,;
2022
PLoS biology, (2022).20 8 10.1371/journal.pbio.3001755.
Transmission of gram-negative antibiotic-resistant bacteria following differing exposure to antibiotic-resistance reservoirs in a rural community: a modelling study for bloodstream infections.
ALLEL, K; Goscé, L; Araos, R; Toro, D; Ferreccio, C; Munita, JM; Undurraga, EA; Panovska-Griffiths, J;
2022
Scientific Reports, (2022).12 1 10.1038/s41598-022-17598-x.
Enhanced tuberculosis screening using computer-aided X-ray diagnosis and novel point of care urine lipoarabinomannan assay among adults with HIV admitted to hospital (CASTLE study): a cluster randomised trial.
Burke, R; Nyirenda, S; Twabi, H; Nliwasa, M; Joekes, E; Walker, N; Nyirenda, R; Gupta-Wright, A; Fielding, K; MacPherson, P; CORBETT, E;
2022
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, (2022).25,
Complexity and evidence in health sector decision-making: lessons from tuberculosis infection prevention in South Africa.
Perera, S; Parkhurst, J; Diaconu, K; BOZZANI, F; VASSALL, A; GRANT, A; Kielmann, K;
2022
Health Policy and Planning, (2022).37 9 10.1093/heapol/czac059.
Investigating resistance in clinical Mycobacterium tuberculosis complex isolates with genomic and phenotypic antimicrobial susceptibility testing: a multicentre observational study.
Finci, I; Albertini, A; Merker, M; Andres, S; Bablishvili, N; Barilar, I; Cáceres, T; Crudu, V; Gotuzzo, E; Hapeela, N; Hoffmann, H; Hoogland, C; Kohl, TA; KRANZER, K; Mantsoki, A; Maurer, FP; Nicol, MP; Noroc, E; Plesnik, S; Rodwell, T; Ruhwald, M; Savidge, T; Salfinger, M; Streicher, E; Tukvadze, N; ... Denkinger, CM.
2022
The Lancet Microbe, (2022).3 9 10.1016/S2666-5247(22)00116-1.
Portable sequencing of Mycobacterium tuberculosis for clinical and epidemiological applications.
Gómez-González, PJ; CAMPINO, S; PHELAN, JE; CLARK, TG;
2022
Briefings in Bioinformatics, (2022).23 5 10.1093/bib/bbac256.
High clustering rate and genotypic drug-susceptibility screening for the newly recommended anti-tuberculosis drugs among global extensively drug-resistant Mycobacterium tuberculosis isolates.
Trisakul, K; Nonghanphithak, D; Chaiyachat, P; Kaewprasert, O; Sakmongkoljit, K; Reechaipichitkul, W; Chaiprasert, A; Blair, D; CLARK, TG; Faksri, K;
2022
Emerging Microbes & Infections, (2022).11 1 10.1080/22221751.2022.2099304.